Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001387131-17-003713
Filing Date
2017-07-20
Accepted
2017-07-20 16:19:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE TO REPORT ACQUISITION OF BENEFICAL OWNERSHIP tappan-sc13g_072017.htm SC 13G 52122
  Complete submission text file 0001387131-17-003713.txt   53780
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Subject) CIK: 0000704562 (see all company filings)

EIN.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: SC 13G | Act: 34 | File No.: 005-37393 | Film No.: 17974577
SIC: 2834 Pharmaceutical Preparations

Mailing Address 33 IRVING PL THIRD FLOOR NEW YORK NY 10003
Business Address 33 IRVING PL SUITE 5024 NEW YORK NY 10003 6463626242
Tappan Street Partners LLC (Filed by) CIK: 0001666737 (see all company filings)

EIN.: 452662859 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G